SCHEMBL21067886

SCHEMBL21067886

O=C(CN1C(=O)[C@@H](NC(=O)c2cc3cc(Cl)sc3[nH]2)Cc2ccccc21)NCCO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PYGL P06737 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5629434 1.00 PYGL (1.00) PYGL
SCHEMBL5630188 0.91 PYGL (0.84) PYGL
SCHEMBL5630014 0.90 PYGL (1.00) PYGL
SCHEMBL5630171 0.89 PYGL (1.00) PYGL
SCHEMBL5630063 0.89 PYGL (0.86) PYGL
SCHEMBL5629310 0.89 PYGL (0.80) PYGL
SCHEMBL5629044 0.88 PYGL (0.85) PYGL
SCHEMBL5629441 0.88 PYGL (1.00) PYGL
SCHEMBL5628840 0.88 PYGL (1.00) PYGL
SCHEMBL14380798 0.88 PYGL (0.84) PYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
Send feedback